
Quest Diagnostics Secures $500 Million in Senior Notes at 5% Interest to Fuel Long-Term Growth
Quest Diagnostics IncorporatedDescription
What this story covers
Quest Diagnostics issued $500 million in 5.000% senior notes due 2036. This strategic debt financing bolsters long-term liquidity and financial flexibility, allowing the company to fund operations and growth initiatives while maintaining a disciplined capital structure through 2036.
Story snapshot
CompanyQuest Diagnostics Incorporated
TickerDGX
VariantStandard detailed
Duration5:04
Filing type8-K
PeriodAnnual 2026
IndustryHealthcare & Pharmaceuticals
Accession0001104659-26-057938
Sources1
Full Story Script
Content not available for this story.